Atea Pharmaceuticals, Inc. Common Stock (AVIR) is a publicly traded Healthcare sector company. As of July 14, 2026, AVIR trades at $4.75 with a market cap of $399.34M and a P/E ratio of -2.46. AVIR moved +0.84% today. Year to date, AVIR is +33.52%; over the trailing twelve months it is +29.16%. Its 52-week range spans $2.46 to $6.45. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces AVIR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for AVIR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $4.75 |
| Market Cap | $399.34M |
| P/E Ratio | -2.46 |
| EPS | $-1.94 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.45 |
| 52-Week Low | $2.46 |
| Volume | 35.28K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-158.35M |
| Gross Margin | 0.00% |
2 analysts cover AVIR: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.